A

Atara Biotherapeutics
D

ATRA

7.18700
USD
0.02
(0.24%)
مغلق
حجم التداول
1,166
الربح لكل سهم
3
العائد الربحي
-
P/E
-3
حجم السوق
42,844,517
أصول ذات صلة
C
CRVS
0.02000
(0.57%)
3.50000 USD
F
FATE
-0.02000
(-1.68%)
1.17000 USD
G
GLYC
-0.00510
(-2.06%)
0.24300 USD
R
RCKT
-0.28500
(-4.35%)
6.26500 USD
R
RGEN
-2.440
(-2.03%)
118.050 USD
T
TXG
-0.37000
(-4.33%)
8.17000 USD
V
VKTX
-0.715
(-2.58%)
26.985 USD
المزيد
الأخبار المقالات

العنوان: Atara Biotherapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).